The US FDA has cleared a rapid PCR-based test for Group B Streptococcus in pregnant women that could help to reduce the number of babies who acquire the organism, a leading cause of illness and death among newborns in the US.
The IDI-Strep B test is a non-culture test, made by Infectio Diagnostic, which can provide results in just one hour....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?